(PARIS) -- A new study says there is an easier way of diagnosing the extent of illness for uterine cancer patients.
Patients with early-stage breast cancer no longer need to have a large number of lymph nodes removed to test for the spread of their cancer.
Now a study in the journal Lancet Oncology finds the same may be true for women with early uterine cancer.
The ongoing research was carried out on 133 women in France.
It concludes that a biopsy on a smaller number of what are called sentinel lymph nodes can diagnose with high accuracy whether the cancer has metastasized. That means women with early uterine cancer don't need to have all their pelvic lymph nodes removed -- greatly reducing the risk of complications such as painful swelling.
In a comment accompanying the study, the journal's editors say the new method could be a "win-win scenario: a more conservative procedure and a more sensitive means" to identify women at high risk and select them for proper therapy.
Copyright 2011 ABC News Radio